Skip to main content

Immunic, Inc.

IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001280776

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 16, 2026
$114.8M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −21 vs. previous quarter
56
13F valueReported value at the end of Q2 2026
$130.6M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$97.2M
No comparable prior period
Free cash flow, FY2025
-$86.0M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.95M
Shares sold short
Change
+88.5K
+4.8% vs. previous
Days to cover
5.73
At average daily volume

Superinvestors holding IMUX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding IMUX at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Immunic, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 20, 2025 (view filing)Jun 515 daysTardio JasonPresident and COOPPurchase+12.5K$0.79+$9.88KNew position12.5K afterAmended
Jun 20, 2025 (view filing)Jun 416 daysVitt DanielCEO and DirectorPPurchase+15.0K$0.77+$11.6K+107.1%29.0K afterAmended
Jun 16, 2025 (view filing)Jun 133 daysNash DuaneExecutive ChairmanPPurchase+20.0K$0.83+$16.6K+124.8%36.0K after
Jun 5, 2025 (view filing)Jun 4-51 dayNeermann JoergDirectorPPurchase+100.0K$0.767+$76.7K+100.0%200.0K after2 lots
Jun 4, 2025 (view filing)Jun 31 dayWhaley GlennChief Financial OfficerPPurchase+45.0K$0.71+$31.9K+89.1%95.5K after
Jun 4, 2025 (view filing)Jun 31 dayRudick Richard AlanDirectorPPurchase+143.1K$0.70+$100.2K+163.9%230.4K after
Nov 13, 2024 (view filing)Nov 121 dayRudick Richard AlanDirectorPPurchase+87.3K$1.15+$100.4KNew position87.3K after
Feb 28, 2024 (view filing)Feb 262 daysVitt DanielPresident and CEOPPurchase+14.0K$1.31+$18.3K+3.7%390.9K after
May 16, 2023 (view filing)May 151 dayWhaley GlennChief Financial OfficerPPurchase+5.00K$1.75+$8.75K+24.4%25.5K after
Dec 15, 2022 (view filing)Dec 13-142 daysNeermann JoergDirectorPPurchase+82.0K$1.26+$103.0K+455.6%100.0K after2 lots

Top 10 13F holders, Q2 2026

See all 56 holders

The largest institutional positions in Immunic, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding IMUX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Standard Life Aberdeen plc824,393$12.7M0.02%00.0%UnchangedConverted for a 1-for-10 split
BVF Inc765,295$11.8M0.30%00.0%UnchangedConverted for a 1-for-10 split
Millennium Management LLC740,347$11.4M0.01%+362,355+95.9%AddedConverted for a 1-for-10 split
Avidity Partners Management LP669,941$10.3M1.65%00.0%UnchangedConverted for a 1-for-10 split
Braidwell LP645,010$9.91M0.37%+645,010New
Laurion Capital Management LP610,326$9.38M0.68%+222,110+57.2%AddedConverted for a 1-for-10 split
Vanguard Capital Management LLC571,561$8.78M0.00%+57,729+11.2%AddedConverted for a 1-for-10 split
Jones Hill Capital LP539,814$8.30M1.76%+539,814New
Woodline Partners LP471,528$7.25M0.02%+374,813+387.5%AddedConverted for a 1-for-10 split
Soleus Capital Management, L.P.450,000$6.92M0.24%00.0%UnchangedConverted for a 1-for-10 split

Holders of 5% or more of IMUX

See all 16 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Immunic, Inc..

Largest holders of IMUX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vivo Opportunity Fund Holdings, L.P.13G9.99%29.1M sharesNewFeb 20, 20261 filingFeb 20, 2026SEC
Biotechnology Value Fund L P13D9.99%13.6M shares0.00 ppfrom 9.99%Jan 18, 20243 filingsFeb 20, 2026SEC
Janus Henderson Group PLC13G9.99%12.0M shares+6.99 ppfrom 3.00%Jan 18, 20244 filingsDec 8, 2025SEC
Adage Capital Management, L.P.13G/A9.99%10.5M shares+8.44 ppfrom 1.55%Nov 12, 20243 filingsAug 12, 2025SEC
Avidity Partners Management LP13G9.90%14.0M shares+5.10 ppfrom 4.80%Jan 16, 20247 filingsApr 17, 2026SEC